Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine.
BACKGROUND: The target enzyme of pyrimethamine is dihydrofolate reductase (DHFR), but little is known about allelic variants of dhfr in Plasmodium vivax populations. Still less is known about associations between specific alleles and the failure of sulfadoxine/pyrimethamine (S/P) to clear the eryth...
Κύριοι συγγραφείς: | Hastings, MD, Porter, K, Maguire, J, Susanti, I, Kania, W, Bangs, M, Sibley, C, Baird, J |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2004
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Effects of point mutations in Plasmodium falciparum dihydrofolate reductase and dihydropterate synthase genes on clinical outcomes and in vitro susceptibility to sulfadoxine and pyrimethamine.
ανά: David J Bacon, κ.ά.
Έκδοση: (2009-08-01) -
Molecular monitoring of the Leu-164 mutation of dihydrofolate reductase in a highly sulfadoxine/pyrimethamine-resistant area in Africa.
ανά: Ochong, E, κ.ά.
Έκδοση: (2003) -
Multiple origins of resistance-conferring mutations in <it>Plasmodium vivax dihydrofolate reductase</it>
ανά: O'Neil Michael T, κ.ά.
Έκδοση: (2008-04-01) -
Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates.
ανά: Imwong, M, κ.ά.
Έκδοση: (2001) -
Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia.
ανά: Lederman, E, κ.ά.
Έκδοση: (2006)